The 2022 OncoAlert Colloquium DAY 1: Breast Cancer
A warm welcome to the third OncoAlert ColloquiumThis year being held in partnership with: The American Society for Radiation OncologyThe European Cancer Orga…
A warm welcome to the third OncoAlert ColloquiumThis year being held in partnership with: The American Society for Radiation OncologyThe European Cancer Orga…
DAY 3 Breast CancerFebruary 7, 2023 Start 6pm CET12 noon EST (Noon)6pm-6:26 CET12 noon-12:26 ESTErika Hamilton: (26 min)ER+ Metastatic Breast Cancer6:26-6:47…
DAY 3 Breast CancerFebruary 7, 2023 Start 6pm CET12 noon EST (Noon)6pm-6:26 CET12 noon-12:26 ESTErika Hamilton: (26 min)ER+ Metastatic Breast Cancer6:26-6:47…
This study of patients with early-stage triple-negative breast cancer not treated with adjuvant or neoadjuvant chemotherapy analyzes the association between tumor-infiltrating lymphocyte levels, cancer recurrence,…
This study of patients with early-stage triple-negative breast cancer not treated with adjuvant or neoadjuvant chemotherapy analyzes the association between tumor-infiltrating lymphocyte levels, cancer recurrence,…
DAY 3 Breast CancerFebruary 7, 2023 Start 6pm CET12 noon EST (Noon)6pm-6:26 CET12 noon-12:26 ESTErika Hamilton: (26 min)ER+ Metastatic Breast Cancer6:26-6:47…
The most powerful, simple and trusted way to gather experience data. Start your journey to experience management and try a free account today.
Novel systemic therapies for breast cancer are being rapidly implemented into clinical practice. These drugs often have different mechanisms of action…
Novel systemic therapies for breast cancer are being rapidly implemented into clinical practice. These drugs often have different mechanisms of action…
Novel systemic therapies for breast cancer are being rapidly implemented into clinical practice. These drugs often have different mechanisms of action…
This retrospective cohort study assesses the cumulative incidence of pregnancy after cancer and disease-free survival in BRCA carriers diagnosed with invasive breast cancer at age…